Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001567619-21-010751

Options or other derivatives

  • Director acquired 22,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
THEUER CHARLES Director 2021-05-17 Grant or award · Stock Option (Right to Buy) +22,500 22,500 D
Loading xslF345X03/doc1.xml…